My little holding is gone. This is the beginning of the M&A action in the cancer sector.
PGL was long ago decided on as a no goer.
The people pulling the strings want the cash and dual listing at a discount.
Watch out for undisclosed short position.
This biotech sector is a sordid corrupt little place.
bought at 58, page-4
-
- There are more pages in this discussion • 153 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
